TY - JOUR
T1 - Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder
AU - Vulink, Nienke C.
AU - Planting, Robin S.
AU - Figee, Martijn
AU - Booij, Jan
AU - Denys, Damiaan
N1 - Publisher Copyright:
© 2015 Elsevier B.V. and ECNP.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Though the dopaminergic system is implicated in Obsessive Compulsive and Related Disorders (OCRD), the dopaminergic system has never been investigated in-vivo in Body Dysmorphic Disorder (BDD). In line with consistent findings of reduced striatal dopamine D2/3 receptor availability in Obsessive Compulsive Disorder (OCD), we hypothesized that the dopamine D2/3 receptor availability in the striatum will be lower in patients with BDD in comparison to healthy subjects. Striatal dopamine D2/3 receptor Binding Potential (BPND) was examined in 12 drug-free BDD patients and 12 control subjects pairwise matched by age, sex, and handedness using [123I]iodobenzamide Single Photon Emission Computed Tomography (SPECT; bolus/constant infusion technique). Regions of interest were the caudate nucleus and the putamen. BPND was calculated as the ratio of specific striatal to binding in the occipital cortex (representing nonspecific binding).Compared to controls, dopamine D2/3 receptor BPND was significantly lower in BDD, both in the putamen (p=0.017) and caudate nucleus (p=0.022).This study provides the first evidence of a disturbed dopaminergic system in BDD patients. Although previously BDD was classified as a separate disorder (somatoform disorder), our findings give pathophysiological support for the recent reclassification of BDD to the OCRD in DSM-5.
AB - Though the dopaminergic system is implicated in Obsessive Compulsive and Related Disorders (OCRD), the dopaminergic system has never been investigated in-vivo in Body Dysmorphic Disorder (BDD). In line with consistent findings of reduced striatal dopamine D2/3 receptor availability in Obsessive Compulsive Disorder (OCD), we hypothesized that the dopamine D2/3 receptor availability in the striatum will be lower in patients with BDD in comparison to healthy subjects. Striatal dopamine D2/3 receptor Binding Potential (BPND) was examined in 12 drug-free BDD patients and 12 control subjects pairwise matched by age, sex, and handedness using [123I]iodobenzamide Single Photon Emission Computed Tomography (SPECT; bolus/constant infusion technique). Regions of interest were the caudate nucleus and the putamen. BPND was calculated as the ratio of specific striatal to binding in the occipital cortex (representing nonspecific binding).Compared to controls, dopamine D2/3 receptor BPND was significantly lower in BDD, both in the putamen (p=0.017) and caudate nucleus (p=0.022).This study provides the first evidence of a disturbed dopaminergic system in BDD patients. Although previously BDD was classified as a separate disorder (somatoform disorder), our findings give pathophysiological support for the recent reclassification of BDD to the OCRD in DSM-5.
KW - Body Dysmorphic Disorder (BDD)
KW - Dopamine D receptor
KW - Obsessive Compulsive and Related Disorders (OCRD)
KW - Single Photon Emission Computed Tomography (SPECT)
UR - http://www.scopus.com/inward/record.url?scp=84958212996&partnerID=8YFLogxK
U2 - 10.1016/j.euroneuro.2015.11.018
DO - 10.1016/j.euroneuro.2015.11.018
M3 - Article
C2 - 26711686
AN - SCOPUS:84958212996
SN - 0924-977X
VL - 26
SP - 350
EP - 356
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
IS - 2
ER -